ATE219371T1 - Verwendung von ginkgo biloba extrakten zur herstellung von pharmazeutischen zusammenstellungen - Google Patents

Verwendung von ginkgo biloba extrakten zur herstellung von pharmazeutischen zusammenstellungen

Info

Publication number
ATE219371T1
ATE219371T1 AT97943121T AT97943121T ATE219371T1 AT E219371 T1 ATE219371 T1 AT E219371T1 AT 97943121 T AT97943121 T AT 97943121T AT 97943121 T AT97943121 T AT 97943121T AT E219371 T1 ATE219371 T1 AT E219371T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
ginkgo biloba
producing pharmaceutical
biloba extracts
extracts
Prior art date
Application number
AT97943121T
Other languages
English (en)
Inventor
Dominique Castelli
Laurence Friteau
Gerd Ries
Original Assignee
Johnson & Johnson Consumer Fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Fr filed Critical Johnson & Johnson Consumer Fr
Application granted granted Critical
Publication of ATE219371T1 publication Critical patent/ATE219371T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT97943121T 1996-10-22 1997-10-21 Verwendung von ginkgo biloba extrakten zur herstellung von pharmazeutischen zusammenstellungen ATE219371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612822A FR2754714B1 (fr) 1996-10-22 1996-10-22 Nouvelles utilisations d'extraits de ginkgo biloba pour la preparation de compositions pharmaceutiques,et methode de traitement cosmetique mettant en oeuvre un extrait de ginkgo biloba
PCT/IB1997/001319 WO1998017295A1 (en) 1996-10-22 1997-10-21 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract

Publications (1)

Publication Number Publication Date
ATE219371T1 true ATE219371T1 (de) 2002-07-15

Family

ID=9496869

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97943121T ATE219371T1 (de) 1996-10-22 1997-10-21 Verwendung von ginkgo biloba extrakten zur herstellung von pharmazeutischen zusammenstellungen

Country Status (17)

Country Link
EP (1) EP0877619B1 (de)
JP (1) JP2000517345A (de)
KR (1) KR19990076619A (de)
CN (1) CN1211925A (de)
AR (1) AR010019A1 (de)
AT (1) ATE219371T1 (de)
AU (1) AU743822B2 (de)
BR (1) BR9706889A (de)
CA (1) CA2240997A1 (de)
CZ (1) CZ195398A3 (de)
DE (1) DE69713484T2 (de)
EA (1) EA000974B1 (de)
ES (1) ES2176786T3 (de)
FR (1) FR2754714B1 (de)
PL (1) PL327540A1 (de)
SK (1) SK87398A3 (de)
WO (1) WO1998017295A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100436384B1 (ko) * 2001-08-24 2004-06-18 조천호 천연식물 추출물로 이루어진 피부개선 화장료 조성물
FR2831443B1 (fr) * 2001-10-30 2005-02-11 Oreal Utilisation d'extraits vegetaux pour ameliorer la fonction barriere de la peau
FR2846242A1 (fr) * 2003-01-17 2004-04-30 Oreal Utilisation cosmetique et/ou dermatologique d'au moins un extrait de ginkgo biloba en tant qu'agent blanchissant
EP1543823A1 (de) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Gingkoextrakt enthaltende kosmetische Zubereitungen zur Verbesserung des Hautglanzes
FR2911782A1 (fr) * 2007-01-31 2008-08-01 Jacqueline Martin Comment guerir du sida avec mentha pulegium et ginkgo biloba
JP2009256270A (ja) * 2008-04-18 2009-11-05 Maruzen Pharmaceut Co Ltd インスリン様成長因子−１発現促進剤
CN102641353B (zh) * 2012-05-15 2014-07-02 何超文 一种富含植物黄酮类物质的生发素
CN106880529A (zh) * 2017-03-30 2017-06-23 辽宁吉瑞生物科技有限公司 一种含银杏提取液的化妆品及其生产工艺
PL234670B1 (pl) * 2017-11-18 2020-03-31 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Zastosowanie wyciągu z liści miłorzębu japońskiego Ginkgo biloba
CN112843080A (zh) * 2021-02-09 2021-05-28 安徽九华华源药业有限公司 抗甲3型流感病毒的组合物及其制备方法
FR3129084B1 (fr) * 2021-11-16 2025-05-23 Larboretum Composition cosmétique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239521A (ja) * 1985-08-14 1987-02-20 Kuraray Co Ltd 免疫増強剤
FR2634380B1 (fr) * 1988-07-19 1990-10-12 Beljanski Mirko Regulateur biologique, actif dans diverses pathologies
JP3076620B2 (ja) * 1991-04-19 2000-08-14 株式会社コーセー 皮膚外用剤

Also Published As

Publication number Publication date
PL327540A1 (en) 1998-12-21
AU743822B2 (en) 2002-02-07
EP0877619A1 (de) 1998-11-18
BR9706889A (pt) 1999-12-28
DE69713484D1 (de) 2002-07-25
CZ195398A3 (cs) 1998-11-11
FR2754714B1 (fr) 1999-01-22
AU4470497A (en) 1998-05-15
EA000974B1 (ru) 2000-08-28
DE69713484T2 (de) 2003-01-30
SK87398A3 (en) 2000-01-18
ES2176786T3 (es) 2002-12-01
JP2000517345A (ja) 2000-12-26
KR19990076619A (ko) 1999-10-15
EP0877619B1 (de) 2002-06-19
EA199800589A1 (ru) 1998-12-24
WO1998017295A1 (en) 1998-04-30
AR010019A1 (es) 2000-05-17
CN1211925A (zh) 1999-03-24
FR2754714A1 (fr) 1998-04-24
CA2240997A1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
DE69903515D1 (de) Zusammensetzung zur herstellung von temporären zahnkronen und haltebrücken
PT1039909E (pt) Metodo de producao e composicao de uma preparacao oral de itraconazole
EP0850042A4 (de) Zusammenzetzung und Verfahren zur Remineralisierung der Zähne
ATE478665T1 (de) Verfahren zur herstellung einer polymorphen form von atorvastatin calcium
DE69811530D1 (de) Verfahren zur herstellung von derivaten der taxoid-klasse
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE69605995D1 (de) Sicherungsplatte und Verfahren zur Herstellung der Sicherungsplatte
ATE219371T1 (de) Verwendung von ginkgo biloba extrakten zur herstellung von pharmazeutischen zusammenstellungen
DE69605835D1 (de) Sicherungsplatte und Verfahren zur Herstellung der Sicherungsplatte
DE69806832D1 (de) Verfahren zur Herstellung von Octaphenylcyclotetrasiloxan und Sym-Tetramethyltetraphenylcyclotetrasiloxan
EP1461056A4 (de) Verfahren zur herstellung und verwendung von polyoxyethyliertem rizinusöl in pharmazeutischen zusammensetzungen
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE59807380D1 (de) Verfahren zur Herstellung von Alpha-Tocopherolestern
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE59606485D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69815179D1 (de) Verfahren zur Herstellung von D-Glucoronsäurelacton
DE69721694D1 (de) Verfahren zur Herstellung von Triethylendiamin
DE69738320D1 (de) Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch
DE59606489D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69706241D1 (de) Pharmazeutische Zusammensetzung zur Behandlung der Leukämie enthaltend 9-cis-Retinoinsäure-alpha-Tocopherolester
DE69901243D1 (de) Artikulator zur herstellung von zahnärztlichen prothesen
DE59500393D1 (de) Verfahren zur Herstellung von Cyclopropylalkylketonen und 4,5-Dihydroalkylfuranen
DE59606616D1 (de) Dicarbonsäurederivate und ihre Verwendung zur Herstellung von Poly-o-hydroxyamiden oder Poly-o-mercaptoamiden
DE69836756D1 (de) Verfahren zur herstellung von xylitol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties